Ulrike Raff

Erlangen, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Blood Pressure Pattern and Target Organ Damage in Patients With Chronic Kidney Disease.

Blood Pressure Pattern and Target Organ Damage in Patients With Chronic Kidney Disease.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: October 26, 2018

Left Ventricular Structure in Patients With Mild-to-Moderate CKD-a Magnetic Resonance Imaging Study.

Left Ventricular Structure in Patients With Mild-to-Moderate CKD-a Magnetic Resonance Imaging Study.

Journal: Kidney international reports

Published: July 12, 2018

Retinal capillary and arteriolar changes in patients with chronic kidney disease.

Retinal capillary and arteriolar changes in patients with chronic kidney disease.

Journal: Microvascular research

Published: December 08, 2017

Low dose-eplerenone treatment decreases aortic stiffness in patients with resistant hypertension.

Low dose-eplerenone treatment decreases aortic stiffness in patients with resistant hypertension.

Journal: Journal of clinical hypertension (Greenwich, Conn.)

Published: August 29, 2016

Increased Aldosterone Release During Head-Up Tilt in Early Primary Hypertension.

Increased Aldosterone Release During Head-Up Tilt in Early Primary Hypertension.

Journal: American journal of hypertension

Published: August 23, 2016

Skin Sodium Concentration Correlates with Left Ventricular Hypertrophy in CKD.

Skin Sodium Concentration Correlates with Left Ventricular Hypertrophy in CKD.

Journal: Journal of the American Society of Nephrology : JASN

Published: June 21, 2016

Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and progression to end stage renal disease.

Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and progression to end stage renal disease.

Journal: PloS one

Published: October 17, 2014

Prevention of electrocardiographic left ventricular remodeling by the angiotensin receptor blocker olmesartan in patients with type 2 diabetes.

Prevention of electrocardiographic left ventricular remodeling by the angiotensin receptor blocker olmesartan in patients with type 2 diabetes.

Journal: Journal of hypertension

Published: October 03, 2014

Olmesartan improves pulse wave velocity and lowers central systolic blood pressure and ambulatory blood pressure in patients with metabolic syndrome.

Olmesartan improves pulse wave velocity and lowers central systolic blood pressure and ambulatory blood pressure in patients with metabolic syndrome.

Journal: Journal of clinical hypertension (Greenwich, Conn.)

Published: August 25, 2014

First experience in analysing pulsatile retinal capillary flow and arteriolar structural parameters measured noninvasively in hypertensive patients.

First experience in analysing pulsatile retinal capillary flow and arteriolar structural parameters measured noninvasively in hypertensive patients.

Journal: Journal of hypertension

Published: August 08, 2014

Circadian rhythm and day to day variability of serum potassium concentration: a pilot study.

Circadian rhythm and day to day variability of serum potassium concentration: a pilot study.

Journal: Journal of nephrology

Published: May 13, 2014

Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes.

Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes.

Journal: Cardiovascular diabetology

Published: October 07, 2013

Showing 1-12 of 20

Last Updated: 09/26/2026